Cancer Detection and Diagnosis Research in Colorado
Cancer Detection and Diagnosis Research (93.394) awarded $17.5 million to recipients in Colorado in 21 grants from fiscal 2021 to 2025, 0.7% of the program's national total. The Regents of the University of Colorado received the most, $6.2 million.
- Awarded in Colorado$17.5 million
- Awards21
- Share of the program0.7%
- Rank among states27th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $1.8 million |
| FY 2022 | 11 | $4.5 million |
| FY 2023 | 12 | $4.4 million |
| FY 2024 | 6 | $2.9 million |
| FY 2025 | 9 | $4.0 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 9 | $6.2 million |
| University of Denver | Colleges and universities | 1 | $2.6 million |
| Fischer Imaging Inc | Small businesses | 1 | $2.0 million |
| Orbit Genomics, Inc. | Small businesses | 1 | $2.0 million |
| Colorado State University | Colleges and universities | 3 | $1.7 million |
| The Regents of the University of Colorado | Colleges and universities | 2 | $1.3 million |
| Pathware Inc. | Small businesses | 2 | $895,144 |
| Trustees of the Colorado School of Mines | Colleges and universities | 1 | $418,826 |
| Darwin Biosciences, Inc. | Small businesses | 1 | $399,998 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Colorado?
$17.5 million from fiscal 2021 to 2025, across 21 awards. Colorado ranks 27th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $6.2 million in 9 awards. Next are University of Denver and Fischer Imaging Inc.
Can organizations in Colorado apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants